Brace yourselves for the SPAC attack
Life-science IPOs may be hitting the wall — so far this year, seven biotech and medical-device startups have yanked their offerings — but one part of the IPO market is booming. That’s the field of “special-purpose acquisition corporations,” or SPACs, which are essentially blank-check companies that raise money through initial offerings specifically for the purpose of acquiring other companies.
At Renaissance Capital’s IPOhome news page (partial screenshot here, as the flow of news will probably throw… Continue Reading